No historical price data available
No price history data available for the selected time period.
Try selecting a different time range.
Company Overview
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Company Information
- CEO
- Robert P. Mauch PharmD
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Employees
- 42000
Contact Information
- Address
- 1 West First Avenue
- Country
- US
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 56.16B market capitalization
- Trading Volume: 1.09M shares traded today
- Price Range: 52-week range of $218.65 - $309.35
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for Cencora, Inc.
Cencora, Inc. (COR) operates in the Medical - Distribution industry within the Healthcare sector. With a current market capitalization of 56.16B, the company represents a significant player in its market. The stock is currently trading at $289.77 with a positivedaily change of 1.25%.
The company's 42000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 33.54, beta of 0.57, and 52-week price range from $218.65 to $309.35when evaluating investment opportunities.
Why Invest in Cencora, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Robert P. Mauch PharmD
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential